Glenmark partners with Pfizer to launch Abrocitinib in India
When launched in India, it will be co-marketed under the brand names JABRYUS and CIBINQO by Glenmark and Pfizer respectively
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
abrocitinib
Pfizer’s phase-III Jade trial shows positive results
The trial compares the efficacy of abrocitinib and dupilumab for moderate-to-severe atopic dermatitisa